Otto Kranendonkfonds

De CALL FOR PROPOSALS 2021

Call for proposals 2021

Open from 1 September 2021 – 15 November 2021

Please note the call for proposals for the Otto Kranendonk Fund (OKF) which is open for research proposals from 1 September to 15 November 2021.

The purpose of the OKF is to stimulate scientific research and knowledge transfer in the area of global health (including tropical medicine) by members of the Netherlands Society for Tropical Medicine and International Health (NVTG). The OKF provides research grants to research which is in line with Sustainable Development Goal 3 (‘ensuring healthy lives and promote well-being for all at all ages’) with a specific focus on low- and middle-income countries or low-resource settings.

The fund is open to members of the NVTG only, who can apply for a grant either as main applicant or as co-applicant. Applicants should be working in the area of global health, including tropical medicine; and at least one of the applicants must work within a health care or research setting within a Low- or Middle-Income Country. Take a look at the Eligibility and funding criteria.

The maximum applicable amount for a proposal is € 10,000. In case multiple funding sources are contributing to the proposed project, the share of the OKF should be specified.

Otto Kranendonk fonds

Het fonds is ingesteld in 1994 als Stichting Erefonds Tropische Geneeskunde. Sinds 2011 staat het op naam van prof. dr. Otto Kranendonk, voorheen buitengewoon hoogleraar tropische gezondheidsleer aan de Universiteit van Amsterdam en directeur van de Afdeling Tropische Hygiëne van het Koninklijk Instituut voor de Tropen. 

Het fonds verleent financiële steun aan wetenschappelijk onderzoek op het gebied van de Tropische Geneeskunde en Internationale Gezondheidszorg. Het doel van deze subsidie is het stimuleren van wetenschappelijk onderzoek ten behoeve van verbetering van de gezondheidszorg in ontwikkelingslanden.

Onderzoek gesubsideerd door het fonds

  • Tiemersma et al. (2015). Delayed cord clamping in South African neonates with expected low birthweight: a randomised controlled trial. Tropical Medicine and International Health. 20(2), 177-183.

  • Beekhuizen et al. Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania). BMC Pregnancy and Childbirth. 2009, 9:48.